These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8287868)

  • 1. Thrombolysis: state of the art.
    Sleight P
    Eur Heart J; 1993 Nov; 14 Suppl G():41-7. PubMed ID: 8287868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
    Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW; Zeitler R; Fitzpatrick P
    Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis after acute myocardial infarction.
    Nee PA
    J Accid Emerg Med; 1997 Jan; 14(1):2-9. PubMed ID: 9023613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy in acute myocardial infarction.
    Paspa PA; Movahed A
    Am Fam Physician; 1992 Feb; 45(2):640-8. PubMed ID: 1739049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy.
    Jafri SM; Walters BL; Borzak S
    J Intensive Care Med; 1995; 10(2):54-63. PubMed ID: 10172420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe use of thrombolysis in the elderly.
    Wittry MD; Thornton TA; Chaitman BR
    Geriatrics; 1989 Nov; 44(11):28-30, 33-6. PubMed ID: 2509296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aspirin with thrombolytic therapy in acute myocardial infarction.
    Hennekens CH
    Chest; 1990 Apr; 97(4 Suppl):151S-155S. PubMed ID: 2108852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic therapy in acute myocardial infarction: an emergency department perspective.
    Walters BL
    Henry Ford Hosp Med J; 1991; 39(3-4):184-94. PubMed ID: 1687142
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic therapy for myocardial infarction.
    Guerci AD
    Md Med J; 1990 Apr; 39(4):377-81. PubMed ID: 2110282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis after acute myocardial infarction. Who should be added to inclusion criteria?
    Figueredo VM; Amidon TM; Wolfe CL
    Postgrad Med; 1994 Dec; 96(8):30-4, 37-40. PubMed ID: 7991476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. After ISIS-3.
    Hannaford PC; Kay CR
    Lancet; 1992 May; 339(8803):1225; author reply 1226-7. PubMed ID: 1349950
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolytic therapy: pre- and post-GISSI-2, ISIS-3, and GUSTO-1.
    Hennekens CH
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I15-7. PubMed ID: 8156657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy in acute MI. Weighing the risks and benefits.
    Ro KG; Anderson HV
    Postgrad Med; 1990 Dec; 88(8):79-80, 83-6, 89-90 passim. PubMed ID: 2123035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemorrhagic aspects of thrombolytic therapy.
    Samama M
    Eur Heart J; 1990 Aug; 11 Suppl F():15-8. PubMed ID: 2121488
    [No Abstract]   [Full Text] [Related]  

  • 18. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.
    Ketley D; Woods KL
    Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Menon V; Harrington RA; Hochman JS; Cannon CP; Goodman SD; Wilcox RG; Schünemann HJ; Ohman EM
    Chest; 2004 Sep; 126(3 Suppl):549S-575S. PubMed ID: 15383484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of ISIS-3 reported at ACC annual meeting.
    Can J Cardiol; 1991 Apr; 7(3):VI-VII. PubMed ID: 1904302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.